The Instituto Nacional de Cancerología in Mexico City received a linear accelerator and a 4-D tomographic simulator to treat cancer patients [1, 2].

This acquisition represents a critical upgrade in the facility's ability to deliver precise radiation therapy. By integrating these technologies, the institute aims to increase the effectiveness of oncology treatments and lower the daily mortality rate associated with cancer in Mexico [1, 2].

The equipment was provided through the support of the Fundación Río Arronte and the Patronato [1, 2]. These organizations collaborated to ensure the institute could access the latest technology required for complex cancer care, a move intended to bridge gaps in public health infrastructure.

Linear accelerators are used to direct high-energy X-rays or electrons to kill cancer cells. The addition of the 4-D tomographic simulator allows medical teams to better account for the movement of organs and tumors during the breathing cycle, which improves the accuracy of the radiation beam [1, 2].

The arrival of these tools allows the Instituto Nacional de Cancerología to modernize its clinical approach. This modernization is part of a broader effort to reduce the burden of cancer on the Mexican population by providing high-tier diagnostic and treatment options within a nationalized setting [1, 2].

While some regional reports have mentioned similar equipment installations in other countries, the specific delivery of these tools to the Mexico City facility was confirmed by the institute and its donors [1, 2].

The institute aims to increase the effectiveness of oncology treatments and lower the daily mortality rate.

The integration of 4-D imaging and linear acceleration at a national institute indicates a shift toward precision medicine in Mexico's public health sector. By reducing the margin of error in radiation delivery, the facility can potentially treat more aggressive tumors with fewer side effects, reducing the need for patients to seek expensive private care or travel abroad for advanced oncology services.